Western University of Health Sciences and TesoRx, a specialty pharmaceutical company that develops formulations platforms and helps take them to market, held an open house and cut the ribbon on a joint research facility within California State Polytechnic University, Pomona’s Innovation Village on Friday, April 3.
The TesoRx Centre of Excellence will in significant part be dedicated to research being conducted by Dr. Guru Betageri, Associate Dean for WesternU’s Graduate College of Biomedical Sciences and professor of pharmaceutical sciences for the university’s College of Pharmacy. Betageri, a leading expert in the area of liposome drug delivery systems, is a co-founder and chief scientific advisor for TesoRx, and has been instrumental in the development of solid-dose forms of pharmaceuticals now on the market. His recent focus has been on TSX-002, a form of orally administered testosterone.
"WesternU’s commitment to research and the advancement of product development is essential to the University’s evolution as an innovative and entrepreneurial health-care resource," said Philip Pumerantz, PhD, president of WesternU. "Our partnership with TesoRx, and Dr. Betageri’s research on behalf of both these entities, highlights the important medical and pharmacological research being done throughout our University to benefit the communities we serve, as well as the larger world."
The open house and ribbon-cutting was invitation-only. Guests included WesternU and TesoRx officials, Cal Poly Pomona representatives, members of the Pomona City Council, and Pomona Chamber of Commerce board members.
For more information about TesoRx, please visit the company’s website, http://www.tesorx.com/index.html .
Visit http://www.westernu.edu/biomedical-sciences/ for more information about WesternU’s Graduate College of Biomedical Sciences, and http://www.westernu.edu/pharmacy/ for information about the College of Pharmacy.